Source: WardsAuto

Renova Therapeutics: Renova Therapeutics to present key components of FLOURISH gene therapy trial for the treatment of heart failure at Keystone Symposium

SAN DIEGO, Jan.read more

Read full article »
Renova Therapeutics's Competitors | Renova Therapeutics's News | Renova Therapeutics's Financials
Stay up-to-date with the latest news on Renova Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Vijay Mahant's photo - CEO of Renova Therapeutics

CEO

Vijay Mahant

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Renova Therapeutics